Abstract
HIV transmission occurs during pregnancy, childbirth, and breastfeeding, and can be mitigated through measures such as prenatal HIV screening and antiretroviral therapy (ART). Health institutions are gradually releasing it if a woman has an undetectable viral load in her blood. This study aims to determine the viral load of HIV in colostrum from postpartum women using qRT-PCR, following participant selection based on informed consent criteria. The research includes monitoring participants’ prenatal routine, collecting, storing, and processing colostrum, as well as automated RNA extraction and viral RNA quantification via qRT-PCR. Thirteen participants were recruited, 13 samples of colostrum were subsequently collected, meeting eligibility criteria and signing informed consent. These samples were processed and analyzed by qRT-PCR. Six of nine samples analyzed were undetectable, and three were below the detection limit. We observed that patients with undetectable colostrum had been on ART before conception, while those with colostrum samples detectable had a detectable serum viral load at some point during pregnancy. The immunological, biochemical, and socioeconomic impact of non-breastfeeding on maternal-child health is significant, and analyzing the transmissibility potential of colostrum raises questions about possible breastfeeding with reduced risks of HIV transmission. We think that achieving undetectable or below detection limit levels in colostrum of women on ART is feasible, but further research is needed on the condition of breast milk from women living with HIV under current antiretroviral therapies used in Brazil.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Ministry of Health of the Government of Brazil. These funding sources had no role in study design or collection, analysis and interpretation of data.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was submitted for evaluation by the Research Ethics Committee on human beings at the Gaffree and Guinle University Hospital (HUGG) of the Federal University of the State of Rio de Janeiro (UNIRIO), registered, and approved under the number CAAE: 61885722100005258
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript.
